Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)

Summary

The BIRD biobank aims at collecting clinical and biological data from patients suffering from a chronic respiratory disease. The lung cancer subpopulation will be divided into two cohorts to identify biomarkers of cancer. One cohort will include patients with supra-centimetric lung nodule(s) whether surveillance, bronchoscopic or radio-guided biopsy or surgery is indicated, patients suspected of lung cancers requiring diagnostic and/or therapeutic bronchial endoscopy and patients with a known early stage lung cancer (early-stage cohort). The second cohort will include known advanced stage lung cancers (III-IV).

Eligibility

Inclusion Criteria:

* Patients with 1 to 3 lung nodules including one \> 1 cm seen on chest CT
* OR: patients with suspected lung cancer requiring diagnostic and/or therapeutic bronchial endoscopy
* OR: Patient with histologically confirmed lung cancer, whether early stages prior to surgery, locally advanced or metastatic, included before the start of any anti-cancer treatment.
* Patient affiliated or beneficiary of a social security scheme
* Patients who are able to receive and understand information about the study and their participation and who have freely given their signed inform consent before any collection of samples or data necessary for the research (no restriction of rights by the judicial authorities and knowledge of the French language).

Exclusion Criteria:

* Patient deprived of liberty on administrative or judicial decision, or patient under guardianship, curators or safeguard of justice
* Female patients who are pregnant or breastfeeding

Conditions3

Browse More Trials